About Hospira News & Media Investor RelationsIn the CommunitySearch  
Financial Reports
Annual Reports/
Proxies
Quarterly Reports/
Supplemental Tables
2010 Proxy Materials
SEC Filings
Insider Transactions
Tax Information for Shareholders
Investing Overview
Stock Quote
Stock Chart
Shareholder FAQ
Analyst Coverage
News & Events
Press Releases
Presentations
IR Calendar
Email Alerts  
Corporate Governance
Hospira Leadership
Board of Directors
Board Committees
and Charters
Corporate Governance
Guidelines
Share Ownership Guidelines
Long Term
Incentives Policy
Hospira Code of Business Conduct

Receive Email AlertsE-mail Alerts
 

All Releases | Reset Search
Acquisitions | Business/Product | Corporate | Financial

2010 | 2009 | 2008 | 2007 | 2006 | 2005
DateTitle 
08/26/10Hospira to Present at Morgan Stanley Global Healthcare Conference Sept. 13Printer Friendly Version
08/22/10Hospira Japan Receives Approval for New Indication for 'Precedex IV(TM) 200ug'Printer Friendly Version
08/20/10Hospira Announces CEO Succession PlanPrinter Friendly Version
08/12/10Hospira to Host Biosimilars Investor Education EventPrinter Friendly Version
08/02/10Hospira to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Aug. 12Printer Friendly Version
07/28/10Hospira Reports Second-Quarter 2010 ResultsPrinter Friendly Version
07/26/10Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal PatientsPrinter Friendly Version
07/13/10Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related InfectionsPrinter Friendly Version
07/01/10Hospira Announces Successful Completion of Tender Offer for Shares of Javelin PharmaceuticalsPrinter Friendly Version
06/28/10Hospira Announces Intention to Complete Tender Offer for Shares of Javelin PharmaceuticalsPrinter Friendly Version
06/24/10Hospira to Host Conference Call for Second-Quarter 2010 ResultsPrinter Friendly Version
06/22/10Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)Printer Friendly Version
06/17/10Hospira Announces Further Extension of Tender Offer for Shares of Javelin PharmaceuticalsPrinter Friendly Version
06/10/10Nivestim(TM), a New Biosimilar Filgrastim, is Approved in Europe for the Prevention of Febrile Neutropenia Associated With ChemotherapyPrinter Friendly Version
06/07/10Hospira and DURECT Sign Agreement to Develop and Commercialize POSIDUR(TM) (SABER(TM)-Bupivacaine) in the U.S. and CanadaPrinter Friendly Version
06/03/10Hospira Announces Further Extension of Tender Offer for Shares of Javelin PharmaceuticalsPrinter Friendly Version
05/19/10Hospira Announces Extension of Tender Offer for Shares of Javelin PharmaceuticalsPrinter Friendly Version
05/18/10Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
05/14/10Hospira to Standardize Intravenous (I.V.) Administration Sets Portfolio to Non-DEHPPrinter Friendly Version
05/11/10Hospira Highlights a Year of Significant Progress at Its 2010 Annual Meeting of ShareholdersPrinter Friendly Version
05/10/10Hospira to Present at Citi 2010 Global Health Care Conference May 27, 2010Printer Friendly Version
05/06/10Hospira Unveils TheraDoc Anticoagulation Assistant(TM) Knowledge Module to Help Hospitals Comply With Joint Commission Patient Safety GoalPrinter Friendly Version
04/27/10Hospira Reports First-Quarter 2010 ResultsPrinter Friendly Version
04/19/10Hospira and Javelin Pharmaceuticals Enter Into Definitive Merger Agreement for Hospira to Acquire Javelin Pharmaceuticals; Hospira Will Initiate Tender OfferPrinter Friendly Version
04/07/10Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
04/01/10Hospira Announces Agreement on Oxaliplatin Patent ChallengePrinter Friendly Version
03/30/10Hospira Completes Acquisition of Orchid's Generic Injectable Pharmaceuticals BusinessPrinter Friendly Version
03/25/10Hospira to Host Conference Call for First-Quarter 2010 ResultsPrinter Friendly Version
03/05/10Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
03/02/10UAB Hospital to Integrate Advanced Symbiq(TM) Infusion Device With EHR to Enhance Safety and Clinician WorkflowPrinter Friendly Version
03/01/10HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality MeasuresPrinter Friendly Version
03/01/10HIMSS Interoperability Showcase to Feature Hospira MedNet(TM), Demonstrating Interoperability as Key to Advancing HealthcarePrinter Friendly Version
02/10/10Hospira Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Orchid's Generic Injectable Pharmaceuticals BusinessPrinter Friendly Version
02/04/10Hospira Reports Fourth-Quarter and Full-Year 2009 ResultsPrinter Friendly Version
01/29/10Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 ProjectionsPrinter Friendly Version
01/22/10Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash GrantsPrinter Friendly Version
01/11/10Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010Printer Friendly Version
12/23/09Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010Printer Friendly Version
12/16/09Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 ProjectionsPrinter Friendly Version
12/15/09Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals BusinessPrinter Friendly Version
12/07/09Lancaster General Hospital Releases Infusion Pump/EHR Interoperability Data - Auto Programming Provides an Additional Layer of SafetyPrinter Friendly Version
12/04/09Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. ContainersPrinter Friendly Version
12/02/09Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management OfferingsPrinter Friendly Version
11/18/09Our Lady of the Lake Connects Infusion Pumps to the EHR to Help Decrease Errors and Improve CarePrinter Friendly Version
11/06/09Hospira to Present at Piper Jaffray 21st Annual Health Care Conference Dec. 2Printer Friendly Version
10/29/09Healthcare Industry Celebrates 25 Years of Advanced Pain Management With PCA Infusion SystemPrinter Friendly Version
10/27/09Hospira Reports Third-Quarter 2009 ResultsPrinter Friendly Version
10/20/09Hospira Names Daphne E. Jones Chief Information OfficerPrinter Friendly Version
10/12/09Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11Printer Friendly Version
10/08/09Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric DrugsPrinter Friendly Version
09/30/09Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVAPrinter Friendly Version
09/28/09Hospira to Host Conference Call for Third-Quarter 2009 ResultsPrinter Friendly Version
09/16/09Hospira to Present at UBS Global Life Sciences Conference Sept. 23Printer Friendly Version
09/10/09Hospira to Host 2009 Investor DayPrinter Friendly Version
08/31/09Hospira Receives FDA Approval for Six New Presentations of HeparinPrinter Friendly Version
08/11/09Hospira Launches Generic Oxaliplatin InjectionPrinter Friendly Version
07/29/09Hospira Reports Second-Quarter 2009 ResultsPrinter Friendly Version
07/09/09ICU Medical, Inc. to Acquire Hospira's Critical Care Product LinePrinter Friendly Version
06/30/09Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices AgreementPrinter Friendly Version
06/29/09Hospira Receives FDA Approval for Azithromycin for InjectionPrinter Friendly Version
06/26/09Hospira to Host Conference Call for Second-Quarter 2009 ResultsPrinter Friendly Version
06/18/09Hospira Receives Favorable Court Decision on Eloxatin(R)Printer Friendly Version
05/20/09Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
05/19/09Hospira Announces Plans to Integrate Symbiq(R) and EndoTool(R) TechnologiesPrinter Friendly Version
05/14/09Hospira Highlights Five Years of Progress and Future Opportunities at Its 2009 Annual Meeting of ShareholdersPrinter Friendly Version
05/07/09Hospira Receives FDA Approval for 10 Gram Vial of Sterile Vancomycin Hydrochloride, USPPrinter Friendly Version
05/07/09Hospira to Present at Bank of America and Merrill Lynch 2009 Health Care Conference May 13Printer Friendly Version
05/05/09Hospira Launches Biologics 'Clock' and Web Resource to Raise Awareness of Potential Biogenerics' ImpactPrinter Friendly Version
04/28/09Hospira Reports First-Quarter 2009 ResultsPrinter Friendly Version
04/27/09Hospira Names Brian Meadows Supply Chain ChiefPrinter Friendly Version
03/30/09Hospira to Host Conference Call for First-Quarter 2009 ResultsPrinter Friendly Version
03/24/09Hospira Announces Plans to Optimize Operations, Increase Shareholder ValuePrinter Friendly Version
03/23/09Hospira to Host Investor Conference Call March 24, 2009Printer Friendly Version
03/11/09Hospira Supports Newly Introduced Biogenerics LegislationPrinter Friendly Version
03/10/09Hospira to Present at Cowen and Company's 29th Annual Health Care Conference March 17Printer Friendly Version
03/09/09Hospira Expands Board of DirectorsPrinter Friendly Version
02/25/09Hospira Advances Patient Safety With New GemStar SP Infusion SystemPrinter Friendly Version
02/17/09Hospira Reports Fourth-Quarter and Full-Year 2008 ResultsPrinter Friendly Version
02/02/09Hospira's Precedex Phase IV Study Published in the Journal of The American Medical AssociationPrinter Friendly Version
01/26/09Hospira to Host Conference Call for Fourth-Quarter 2008 Results and 2009 ProjectionsPrinter Friendly Version
12/29/08Hospira to Present at J.P. Morgan's 27th Annual Healthcare Conference January 14Printer Friendly Version
11/10/08Hospira Names Ken Meyers to Lead Human ResourcesPrinter Friendly Version
11/05/08Hospira Reports Third-Quarter 2008 ResultsPrinter Friendly Version
11/04/08Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12Printer Friendly Version
10/30/08FDA Approves New Indication for Hospira's Precedex (Dexmedetomidine HCL) InjectionPrinter Friendly Version
10/13/08Hospira Acquires EndoTool From MD ScientificPrinter Friendly Version
10/07/08Hospira Hosts Conference Call for Third-Quarter 2008 EarningsPrinter Friendly Version
08/27/08Hospira to Present at the Morgan Stanley 2008 Healthcare Conference on September 9Printer Friendly Version
08/21/08Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And EquipmentPrinter Friendly Version
08/06/08Hospira Reports Second-Quarter 2008 ResultsPrinter Friendly Version
07/07/08Hospira Hosts Conference Call for Second-Quarter 2008 EarningsPrinter Friendly Version
06/25/08Hospira Names Dr. Sumant Ramachandra Chief Scientific OfficerPrinter Friendly Version
05/21/08Hospira Supports Disaster Relief Efforts in Myanmar and ChinaPrinter Friendly Version
05/13/08Hospira Expands Board of DirectorsPrinter Friendly Version
05/13/08Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of ShareholdersPrinter Friendly Version
05/07/08Hospira Reports First-Quarter 2008 ResultsPrinter Friendly Version
04/30/08Hospira Acquires SculptorPrinter Friendly Version
04/30/08Hospira to Present at the Bank of America 2008 Health Care Conference on May 14Printer Friendly Version
04/04/08Hospira Hosts Conference Call for First-Quarter 2008 EarningsPrinter Friendly Version
03/06/08Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13 Printer Friendly Version
02/28/08Hospira Reports Fourth-Quarter and Full-Year 2007 ResultsPrinter Friendly Version
02/27/08Hospira Launches Generic Irinotecan InjectionPrinter Friendly Version
02/26/08Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and EquipmentPrinter Friendly Version
01/17/08Hospira Hosts Conference Call For Fourth-Quarter 2007 Results and 2008 ProjectionsPrinter Friendly Version
12/26/07Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9Printer Friendly Version
12/19/07Hospira's Retacrit™ Receives Marketing Authorization in the EUPrinter Friendly Version
11/08/07Hospira Reports Third-Quarter 2007 ResultsPrinter Friendly Version
10/31/07Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13Printer Friendly Version
10/18/07Hospira's Biosimilar Epoetin Retacrit™ Receives Positive Opinion Recommending EU ApprovalPrinter Friendly Version
10/03/07Hospira Hosts Conference Call for Third-Quarter 2007 EarningsPrinter Friendly Version
09/20/07Hospira Wins Most Valuable Pollution Prevention Award for VisIV™ ContainerPrinter Friendly Version
09/06/07Biogenerics Will Save Billions, Says Hospira CEOPrinter Friendly Version
08/31/07Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11Printer Friendly Version
08/08/07Hospira Reports Second-Quarter 2007 ResultsPrinter Friendly Version
07/09/07Hospira Hosts Conference Call for Second-Quarter 2007 EarningsPrinter Friendly Version
05/30/07Hospira to Host Inaugural Investor DayPrinter Friendly Version
05/15/07Hospira Highlights Strategic Progress at its 2007 Annual Meeting of ShareholdersPrinter Friendly Version
05/09/07Hospira Reports First-Quarter 2007 ResultsPrinter Friendly Version
04/06/07Hospira Hosts Conference Call for First-Quarter 2007 EarningsPrinter Friendly Version
04/04/07Hospira Introduces Advanced Wireless Security Platform for Infusion DevicesPrinter Friendly Version
02/28/07Hospira Reports Fourth-Quarter and Full-Year 2006 ResultsPrinter Friendly Version
02/22/07Hospira Announces Collaborations to Interface Hospital Technologies and Improve Patient SafetyPrinter Friendly Version
02/01/07Hospira Completes Acquisition of Mayne Pharma, Announces New Commercial Leadership StructurePrinter Friendly Version
01/30/07Hospira to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7Printer Friendly Version
01/19/07Hospira Hosts Conference Call for Fourth-Quarter 2006 Results and 2007 ProjectionsPrinter Friendly Version
01/18/07Hospira Acquisition Of Mayne Pharma Clears U.S. Antitrust ReviewPrinter Friendly Version
12/28/06Hospira to Present at the JPMorgan 25th Annual Healthcare Conference January 9Printer Friendly Version
12/26/06Hospira Launches Ondansetron InjectionPrinter Friendly Version
11/20/06Hospira, STADA and BIOCEUTICALS Enter Into Agreements for ErythropoietinPrinter Friendly Version
11/08/06Hospira Reports Third-Quarter 2006 ResultsPrinter Friendly Version
10/31/06Hospira Expands Board of DirectorsPrinter Friendly Version
10/30/06Hospira Hosts Conference Call for Third-Quarter 2006 Earnings Printer Friendly Version
10/16/06Hospira Unveils Symbiq™ Next-Generation Infusion SystemPrinter Friendly Version
10/12/06Health Alliance of Greater Cincinnati Announces Agreement With Hospira to Replace Entire Fleet of Intravenous (I.V.) Pumps Across Seven HospitalsPrinter Friendly Version
10/06/06Hospira Hosts Conference Call for Third-Quarter 2006 EarningsPrinter Friendly Version
09/26/06Hospira Signs Agreement to Provide Pain Management Infusion Pumps to Premier-Member HospitalsPrinter Friendly Version
09/20/06Hospira Announces $2 Billion Agreement to Acquire Mayne PharmaPrinter Friendly Version
09/19/06Hospira Named to Human Rights Campaign's "Best Places to Work" ListPrinter Friendly Version
09/07/06Hospira Announces New Contract With HealthTrust To Provide Pain Management Infusion Pumps To MembersPrinter Friendly Version
08/31/06Hospira To Present At The Bear Stearns 19th Annual Healthcare Conference On September 11thPrinter Friendly Version
08/14/06Hospira Foundation Grant Supports Programs to Lessen Fear and Isolation Felt by Seriously Ill ChildrenPrinter Friendly Version
08/11/06Hospira Names Thomas E. Werner as Chief Financial OfficerPrinter Friendly Version
08/09/06Hospira Reports Second-Quarter 2006 ResultsPrinter Friendly Version
07/06/06Hospira Hosts Conference Call for Second-Quarter 2006 EarningsPrinter Friendly Version
05/17/06Hospira Convenes Its Second Annual Meeting of ShareholdersPrinter Friendly Version
05/09/06Hospira Reports First-Quarter 2006 ResultsPrinter Friendly Version
04/25/06Hospira Appoints Terrence C. Kearney To Newly Created COO PositionPrinter Friendly Version
04/24/06Hospira and InnerWireless Partner to Enhance Connectivity Between Hospital Systems and Medication Management DevicesPrinter Friendly Version
04/19/06Hospira Introduces the VISIV™ Container, the First Significantly Advanced I.V. Bag in More Than 30 YearsPrinter Friendly Version
04/11/06Hospira Hosts Conference Call for First-Quarter 2006 EarningsPrinter Friendly Version
04/03/06Hospira Becomes Chicago Area's Latest FORTUNE 1000 CompanyPrinter Friendly Version
03/31/06Hospira Nominates Ronald A. Matricaria And Mark F. Wheeler For Election To BoardPrinter Friendly Version
02/28/06Hospira Reports Fourth-Quarter and Full-Year 2005 ResultsPrinter Friendly Version
02/28/06Hospira Board Authorizes $400 Million Share Repurchase ProgramPrinter Friendly Version
02/16/06Hospira Joins State Of Kansas And Kansas Bioscience Authority To Announce $60 Million Investment In McPherson Manufacturing FacilityPrinter Friendly Version
02/13/06Hospira Introduces LifeCare PCA(R) Infusion SystemPrinter Friendly Version
02/01/06Hospira Announces Further Plans To Optimize Manufacturing OperationsPrinter Friendly Version
01/31/06Hospira to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7Printer Friendly Version
01/12/06Hospira Hosts Conference Call For 2006 Projections And Fourth-Quarter EarningsPrinter Friendly Version
01/05/06Hospira to Present At The JPMorgan 24th Annual Healthcare Conference On January 10Printer Friendly Version
12/12/05Hospira Introduces Plum A+®3 Infusion System With Hospira MedNet® SoftwarePrinter Friendly Version
11/10/05Hospira Reports Third-Quarter 2005 ResultsPrinter Friendly Version
11/04/05Hospira Announces Strategic Alliance With PharmaLink And Zuellig Pharma In AsiaPrinter Friendly Version
11/01/05Hospira And Cerner Announce Availability Of Point-Of-Care I.V. Medication Management SolutionPrinter Friendly Version
10/24/05Hospira Launches Next-Generation SEDLine™ Brain-Function Monitoring SystemPrinter Friendly Version
10/10/05Hospira Hosts Conference Call For Third-Quarter EarningsPrinter Friendly Version
09/07/05Hospira to Present at the Bear Stearns 18th Annual Healthcare Conference on September 13Printer Friendly Version
08/31/05Hospira Foundation Supports Hurricane Katrina Relief With Up To $300,000Printer Friendly Version
08/23/05Hospira Announces Plans To Close Plant In Donegal, IrelandPrinter Friendly Version
08/11/05Hospira Reports Second-Quarter 2005 ResultsPrinter Friendly Version
08/01/05Hospira Completes Physiometrix AcquisitionPrinter Friendly Version
07/20/05Hospira Ships First Orders Of Ceftriaxone InjectionPrinter Friendly Version
07/12/05Hospira Hosts Conference Call For Second-Quarter EarningsPrinter Friendly Version
06/01/05Hospira To Acquire PhysiometrixPrinter Friendly Version
05/12/05Hospira Reports First-Quarter 2005 ResultsPrinter Friendly Version
05/11/05Hospira to Present at the Banc of America Securities Health Care Conference on May 17Printer Friendly Version
05/10/05Hospira Introduces Wireless Version Of Its Hospira MedNet™ SystemPrinter Friendly Version
05/09/05Hospira Convenes Its First Annual Meeting of ShareholdersPrinter Friendly Version
04/11/05Hospira Hosts Conference Call For First-Quarter EarningsPrinter Friendly Version
04/01/05Hospira Nominates Judith C. Pelham, Former Trinity Health CEO, For Election To BoardPrinter Friendly Version
03/02/05Hospira Reports Fourth-Quarter and Full-Year 2004 ResultsPrinter Friendly Version
02/28/05Hospira And ICU Medical Sign Manufacturing, Commercialization And Development Agreement For Critical Care ProductsPrinter Friendly Version
02/14/05Hospira And Bridge Medical Announce Agreement To Develop New Medication Management Solution For Use At The Patient BedsidePrinter Friendly Version
02/03/05Hospira to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference On February 10Printer Friendly Version
01/25/05Hospira Announces Projections For 2005Printer Friendly Version
01/24/05Hospira Hosts Conference Calls For 2005 Projections And Fourth-Quarter EarningsPrinter Friendly Version
01/10/05Hospira to Present at the JPMorgan 23rd Annual Healthcare Conference on January 12Printer Friendly Version
12/30/04Hospira Supports Tsunami Disaster Relief With $300,000 And Medical Product DonationsPrinter Friendly Version
12/06/04ASHP Foundation And Hospira Announce Expanded Donor-Matching Program Printer Friendly Version
11/09/04Hospira Reports Third-Quarter 2004 ResultsPrinter Friendly Version
10/11/04Hospira Hosts Conference Call For Third-Quarter EarningsPrinter Friendly Version
09/23/04Hospira to Increase Its Non-DEHP Medical Device Portfolio by 50 PercentPrinter Friendly Version
09/09/04Hospira to Present at the Bear Stearns 17th Annual Healthcare Conference on September 13 Printer Friendly Version
08/25/04Hospira Expands Board of DirectorsPrinter Friendly Version
08/10/04Hospira Reports Second-Quarter 2004 ResultsPrinter Friendly Version
07/29/04Hospira Launches Fluconazole InjectionPrinter Friendly Version
07/26/04Hospira Joins The Generic Pharmaceutical AssociationPrinter Friendly Version
07/15/04Hospira And Consorta Enhance Medication Management PartnershipPrinter Friendly Version
07/12/04Hospira Hosts Conference Call For Second-Quarter EarningsPrinter Friendly Version
06/02/04Hospira Expands Manufacturing Capacity Through Purchase Of Fresenius Kabi's Clayton, N.C., FacilityPrinter Friendly Version
05/12/04Hospira Responds To Mini-Tender OfferPrinter Friendly Version
05/03/04Hospira Launches As New, Independent, Global Hospital Products CompanyPrinter Friendly Version
This Web site and its information is intended for use by United States residents only. Countries outside the United States may have regulatory requirements, data requirements or medical practices that differ from the United States and, therefore, this information may be inappropriate for use outside the United States. Site contents are intended for informational purposes only and not intended to replace discussion with a healthcare provider. If you have any questions regarding this site, contact Hospira.

9-084-IR